RELA and prostate carcinoma: The enhancement of VSV oncolysis by vorinostat in prostate cancer cells was traced back to the reversible induction of nuclear factor kappa B (NF-κB) signalling through increased acetylation, nuclear translocation and DNA binding activity of the NF-κB subunit RELA/p65.